GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
1

1CM EPIC.CN · CAD

Health Care · Canadian Securities Exchange · 🇨🇦 Canada

Compare

0.18

0.00%

Close of 4 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About 1CM

Its shares trade on Canadian Securities Exchange under the ticker EPIC.CN. It has been listed since 3 February 2012. In the fiscal year to 31 August 2025, it reported revenue of C$73.4m and net income of C$484,849. At that date it held total assets of C$41.9m and shareholders' equity of C$28.9m.

1CM, Inc. is a multi-jurisdictional cannabinoid producer. The company is headquartered in Markham, Ontario. The company went IPO on 2012-02-03. The firm's segments include Cultivation, Investment Property, Distribution, Marketing and Corporate and other. The Cultivation segment is the cultivation, processing, and distribution division in Canada, United States and South America. The Investment Property segment relates to the investment property. The Distribution segment relates to cannabis retail operations. The Marketing segment relates to the technology solutions provided to both consumers and businesses seeking information in saturated markets, and businesses looking for single-source software. The firm is focused on expanding its operations through organic growth and by way of merger and acquisition transactions.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
3 Feb 2012
Website
1cminc.com ↗

Leadership

Pay as last reported

  • Ms. Tanvi BhandariChief Executive Officer and Director, since 2022C$984,345
  • Mr. Lucas LeoneIndependent DirectorC$42,000
  • Ms. Rupalee MehtaIndependent DirectorC$42,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Multi-jurisdictional cannabinoid producer with operations in Canada, US, and South America.
  • Cultivation segment covers cultivation, processing, and distribution across three continents.
  • Marketing segment offers technology solutions for saturated markets and single-source software.

Weaknesses

  • Investment Property segment relates to investment property without clear revenue streams.
  • Distribution segment focuses on cannabis retail operations with high regulatory risks.
  • Corporate and other segment includes unspecified activities with limited transparency.

Opportunities

  • Expansion through organic growth and merger and acquisition transactions.
  • Cultivation segment can leverage global markets for cannabinoid production.
  • Marketing segment can target businesses seeking information in saturated markets.

Threats

  • Regulatory risks in cannabis retail operations across multiple jurisdictions.
  • Cultivation segment faces challenges in processing and distribution in South America.
  • Investment Property segment lacks defined growth strategies.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.